Form 4 for EDIT Editas Medicine, Inc.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-15 · accession 0001415889-22-006631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-15 | EDIT | Shearman Mark S | EVP, CSO | S - Sale | $10.06 | -5,145 | 68.3K | -7% | -$51.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | S | D | 5,145 | $10.06 | 68,349 | D | — | — |